Print
|
Close
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Active:
Yes
Cancer Type:
Colon/Rectal Cancer
NCT ID:
NCT07321106
Trial Phases:
Phase I
Protocol IDs:
CBI-1214-001 (primary)
NCI-2026-01990
Eligibility:
18 Years and older, Male and Female
Study Type:
Treatment
Study Sponsor:
Cartography Biosciences
NCI Full Details:
http://clinicaltrials.gov/show/NCT07321106
Summary
This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor
activity of CBI-1214 in participants with advanced or metastatic Microsatellite Stable
(MSS)/Microsatellite Instability Low (MSI-L) Colorectal Cancer
Treatment Sites in Georgia
Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu
**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts...
Click here to learn more about clinical trials
.